Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FK925
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,939
Award facts
- Contract value 100% obligated
- $13,939.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,939.30 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a competitive award with no set-aside designation. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly doing business as AmerisourceBergen), a major pharmaceutical distributor providing comprehensive healthcare solutions to federal agencies.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., holds an expanded IDC with DLA extending through December 31, 2031, also valued at up to $999,999,999.00. These overarching contracts serve as comprehensive global pharmaceutical support vehicles, enabling the supplier to deliver a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs, the Defense Health Agency, and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FK925?
SPE2DR26FK925 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FK925 worth?
The government has obligated $13,939 on SPE2DR26FK925.
Is contract SPE2DR26FK925 an order under another contract?
Yes. SPE2DR26FK925 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK925 competed?
The extent of competition for SPE2DR26FK925 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award